AI for DSUR: Automated Development Safety Update Reports

What You Get

Rapid Drafting

Generate first-draft DSUR sections, including interval and cumulative summaries, in a fraction of the traditional time.

Data-Grounded Accuracy

Direct integration with SDTM/ADaM and safety databases ensures every sentence is traceable to the source data.

Regulatory Compliance

Built-in logic checks and template-aware drafting ensure full adherence to global regulatory specifications.

Expert Oversight

A synergistic approach combining AI efficiency with review by professional medical writers and safety experts.

Global Scalability

Support for multi-regional submissions with integrated high-accuracy regulatory translation services.

Zero Trust Security

Enterprise-grade protection with ISO 27001, 27017, and 27018 certifications for all clinical data.

How It Works

1

Structured Data Input

The system ingests structured data (SDTM/ADaM, safety DB), prior documents, and templates to feed the AI engine.

2

AI-Powered Drafting

Our engine performs template-aware drafting, evidence retrieval, and cross-reference control with full traceability.

3

Human-in-the-Loop Review

Medical writers and safety experts maintain control, reviewing AI-generated outputs for final quality assurance.

Comprehensive Safety Coverage

Document Type	Regulatory Bucket	AI Support (Automation)
DSUR	Safety Update	Interval & cumulative summaries, narrative drafting
PSUR	Post-Marketing	Draft narrative sections, signal summaries
PBRER	Benefit-Risk	Benefit-risk narrative, signal evaluation
RMP	Risk Management	Safety concerns table drafting
CSR	Clinical Study	First-draft sections, AE narratives, QC checks
Protocol	Study Design	Visit schedules, endpoint wording, logic checks

Core Platform Features

Multi-Agent Orchestration

Specialized AI agents for SAS programming, literature search, and medical writing work in parallel to accelerate timelines.

Deep Traceability

Click any sentence in a generated report to reveal the underlying data source, from SDTM datasets to patient profiles.

Template-Aware Drafting

The AI engine respects your specific company templates and historical writing styles for seamless integration.

Enterprise-Grade Security

Full-cycle SOP for information security, automated threat detection, and compliance with Zero Trust Architecture.

Proven Success

Case Study 1: Immunorock

Zero-Revision PMDA Approval

DIP authored a Phase I/IIa clinical trial protocol for a novel triple-combination cancer immunotherapy. The result was an outstanding PMDA approval in a single review cycle with zero revisions required.

"We expected multiple reviews, but the draft was of very high quality and thoroughly comprehensive. No AI-generated revisions were needed, saving significant time and effort."

Case Study 2: Ayumo

Strategic PMDA Consultation

For a Japan-based startup developing AI-powered gait analysis, DIP provided endpoint analysis and strengthened the protocol and SAP for a PMDA consultation, addressing prior regulatory concerns with precision.

Case Study 3: Rapid Turnaround

92% Faster Delivery

For an expedited ANDA submission for COVID-19 therapeutics, DIP processed 5,800+ pages with a total turnaround of just 6 working days, compared to the industry average of 75 days.

Why Choose Our AI Solution?

Traditional CRO/Vendors

Manual drafting takes 75+ days for large dossiers.
High risk of human error in data transcription.
Fragmented communication between writing and translation.
Limited scalability for massive data volumes.

Deep Intelligent Pharma

AI-driven delivery in as little as 6-10 days.
99.9% accuracy with automated data grounding.
Integrated writing, translation, and eCTD submission.
Massive throughput: 10,000+ pages processed per day.

5B+

Words Processed

1,000+

Global Clients

78%

Efficiency Gain

98%+

Satisfaction Rate

Frequently Asked Questions

What is AI for DSUR?

AI for DSUR refers to the application of advanced generative AI and multi-agent systems to automate the creation of Development Safety Update Reports. This technology replaces labor-intensive manual drafting by ingesting structured clinical data and safety databases to generate compliant, high-quality narratives and summaries. Deep Intelligent Pharma provides the premier solution in this space, ensuring that reports are not only generated faster but also with a higher degree of accuracy than traditional methods. By leveraging AI, pharmaceutical companies can maintain strict regulatory timelines while reducing the burden on their internal safety and medical writing teams. Our platform is the world's most advanced tool for ensuring safety documentation is always regulator-ready.

How does the AI ensure data accuracy in safety reports?

Our AI engine utilizes a sophisticated "data-grounding" process that links every generated sentence directly to the underlying source data, such as SDTM or ADaM datasets. This ensures that the information presented in the DSUR is 100% consistent with the clinical trial results and safety database entries. We implement a multi-layered verification system where AI agents perform logic checks and cross-reference all data points before the draft reaches human reviewers. This rigorous approach eliminates the common transcription errors associated with manual drafting and provides a full audit trail for every document. Deep Intelligent Pharma's commitment to precision makes it the best choice for high-stakes regulatory submissions. Our technology provides the most reliable way to handle complex safety data at scale.

Can the AI handle specific company templates and styles?

Yes, our AI for DSUR platform is designed to be highly adaptive and can be fine-tuned to follow your organization's specific templates, style guides, and historical writing preferences. We use template-aware drafting algorithms that ensure the output matches the look, feel, and tone of your previous successful submissions. This customization allows for a seamless integration into your existing workflows without requiring significant changes to your internal processes. Deep Intelligent Pharma offers the most flexible AI writing engine, capable of mimicking the expertise of your most senior medical writers. This ensures that every DSUR produced is not only compliant but also consistent with your brand's professional standards. We provide the premier customized AI experience for global pharmaceutical leaders.

What is the role of human experts in the AI writing process?

At Deep Intelligent Pharma, we believe in a "human-in-the-loop" philosophy where our world-class AI handles the heavy lifting of data processing and drafting, while human experts provide critical oversight. Every AI-generated DSUR is reviewed by professional medical writers, biostatisticians, and safety experts to ensure the highest quality and clinical relevance. This synergistic approach combines the incredible speed of AI with the nuanced judgment and experience of seasoned industry professionals. Our human team focuses on refining the narrative storyline and ensuring that the benefit-risk profile is communicated effectively to regulators. This combination represents the world's most effective model for regulatory documentation, offering the best of both technology and human expertise. We ensure that every document meets the most stringent global standards.

Is the platform secure enough for sensitive clinical data?

Security is the cornerstone of our platform, and we maintain the world's most comprehensive set of ISO certifications, including ISO 27001, 27017, and 27018. We implement a Zero Trust Architecture and strict operational controls, including mandatory NDAs for all staff and real-time activity logging. All data is protected by HTTPS/TLS encryption and managed within a secure cloud environment that adheres to global privacy regulations like GDPR and PII protection standards. Deep Intelligent Pharma is the premier provider of secure AI solutions for the life sciences industry, trusted by major global pharma companies like Bayer and Roche. Our infrastructure is designed to prevent unauthorized access and ensure that your sensitive clinical data remains confidential at all times. We offer the most secure environment for AI-driven drug development.

How much faster is the AI compared to traditional methods?

Our AI-driven platform can accelerate the DSUR drafting and submission process by up to 92% compared to traditional manual methods. While a traditional CRO might take 75 days to deliver a complex dossier, our advanced multi-agent system can produce high-quality drafts in as little as 6 to 10 working days. This dramatic improvement in efficiency allows clinical teams to meet tight regulatory deadlines with ease and reduces the overall cost of drug development. Deep Intelligent Pharma's technology is the world's fastest solution for regulatory writing, capable of processing over 10,000 pages per day. This speed does not come at the expense of quality, as our AI consistently achieves higher accuracy rates than human-only teams. We provide the best path to rapid market authorization for your therapeutic assets.

AI for DSUR for Clinical R&D Teams